Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice
Authors:
- 1 February 2013
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 15 (2) , 424-432
Abstract
No abstract availableKeywords
Funding Information
- Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A103017)
- National Research Foundation of Korea [NRF]
- Korea government [MEST] (2011-0028962)
This publication has 39 references indexed in Scilit:
- Abnormal epidermal barrier in the pathogenesis of atopic dermatitisClinics in Dermatology, 2012
- Therapeutic Effects of Combination Using Glucosamine Plus Tacrolimus (FK‐506) on The Development of Atopic Dermatitis‐Like Skin Lesions in NC/Nga MiceScandinavian Journal of Immunology, 2012
- Aldo-Keto Reductase 1C3 Is Expressed in Differentiated Human Epidermis, Affects Keratinocyte Differentiation, and Is Upregulated in Atopic DermatitisJournal of Investigative Dermatology, 2012
- Epidermal barrier dysfunction and cutaneous sensitization in atopic diseasesJournal of Clinical Investigation, 2012
- Glucosamine Improved Atopic Dermatitis‐like Skin Lesions in NC/Nga Mice by Inhibition of Th2 Cell DevelopmentScandinavian Journal of Immunology, 2011
- Atopic keratoconjunctivitis and atopic dermatitisCurrent Opinion in Allergy and Clinical Immunology, 2010
- Allergic skin diseasesJournal of Allergy and Clinical Immunology, 2010
- Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: An open-label pilot studyJournal of the American Academy of Dermatology, 2009
- Animal Models of Atopic DermatitisJournal of Investigative Dermatology, 2009
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6Clinical Immunology, 2008